Pioneering Analysis for Rapid Development of Tomorrow´s Drug Molecules

Purpose and goal

The aim of the project is to develop a customer offer based on Vitroprobe´s new technology for characterizing proteins that is ready for commercial application. It mainly includes developing the technology to reliably and confidently provide unique information about protein structures that is of value to potential customers. Based on this, a business model will be formulated where protein structures can be determined for customers on a commercial basis based on the value created.

Expected effects and result

The expected results are that the technology will be reliable with regard to how long and how much resources a characterization project requires to be carried out. The technology is expected to be developed to reliably deliver accurate protein structures, and demonstrate the unique information that can be obtained with the technology. The expected effects are that intended customers in the pharmaceutical industry will be able to characterize new targets and use this to develop new medicines.

Planned approach and implementation

The goals of the project will be reached by developing the method for preparing materials with embedded proteins. The analysis method is improved by finding optimal analysis parameters. Data processing is an important part of achieving the goals, by correctly reconstructing structures from the raw data. Here, AI models can play a role. In order to reach the goal of making the technology commercially ready, business development and developing a business model is an important part of the project.